The breast cancer drug Herceptin is a potentially life-saving treatment that reduces recurrence of the disease among those undergoing chemotherapy. In late March 2011, Ontario announced it will ...

Based on a 70-kilogram individual, Herceptin will cost on average of about $2,700 per cycle every three weeks until the disease worsens, not until the tumour stops growing, as previously reported.

The vials appear to have been stolen from nine batches, Roche said. The counterfeit vials are labeled Italian Herceptin 150 milligrams, and there is evidence of tampering with rubber stoppers ...

Fake Herceptin vials can be identified by batch numbers and expiry dates on vials not matching the outer package, the presence of a liquid in vials meant to contain a powder, or evidence of ...

HERCEPTIN is marketed in Canada and internationally by Roche, in the United States by Genentech and in Japan by Chugai. Since 1998, HERCEPTIN has been used to treat more than 740,000 patients with ...

The agency notes that the vials of Herceptin (trastuzumab), thought to have been stolen in Italy, have been tampered with and “re-introduced under false credentials into the supply chain in some ...

Herceptin's price in Canada is $35,000 to $45,000 annually, depending on a patient's weight. In Ontario alone, the total cost has been pegged at $55-million annually.

Herceptin is a breast cancer drug which is approved for treatment to breast cancer patients with Her-2/neu positive gene, more than 25% of women with breast cancer produce this Her-2 protein in ...

Fake Herceptin vials can be identified by batch numbers and expiry dates on vials not matching the outer package, the presence of a liquid in vials meant to contain a powder, or evidence of tampering ...